AstraZeneca PLC (NASDAQ:AZN)

59.12
Delayed Data
As of Sep 21
 +0.63 / +1.08%
Today’s Change
46.48
Today|||52-Week Range
60.93
+18.26%
Year-to-Date
AstraZeneca (AZN) Up on Enhertu, Imfinzi Cancer Data at ESMO
Sep 21 / Zacks.com - Paid Partner Content
Here's Why Innate Pharma Stock Is Rocketing Higher Today
Sep 17 / MotleyFool.com - Paid Partner Content
Here's Why Everyone's Talking About AstraZeneca Right Now
Sep 21 / MotleyFool.com - Paid Partner Content
Why Moderna and BioNTech Topped the Market Today
Sep 16 / MotleyFool.com - Paid Partner Content
Why AstraZeneca and Surface Oncology Rose Today
Sep 20 / MotleyFool.com - Paid Partner Content
Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet
Sep 16 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Nucala Gets CHMP Nod for 3 Diseases in Europe
Sep 20 / Zacks.com - Paid Partner Content
2 Pharma Stocks You Can Buy and Hold for the Next Decade
Sep 16 / MotleyFool.com - Paid Partner Content
Here's Why Moderna's Stock Could Crash Before the End of 2021
Sep 19 / MotleyFool.com - Paid Partner Content
Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close58.50
Today’s open58.87
Day’s range58.63 - 59.51
Volume8,696,166
Average volume (3 months)9,239,983
Market cap$172.1B
Data as of 4:50pm ET, 09/21/2021

Growth & Valuation

Earnings growth (last year)+137.38%
Earnings growth (this year)+36.51%
Earnings growth (next 5 years)+18.60%
Revenue growth (last year)+13.16%
P/E ratio41.2
Price/Sales4.76
Price/Book9.34

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.04+0.06%
NVSNovartis+0.02+0.02%
ABBVAbbVie+0.75+0.70%
NVONovo Nordisk+2.11+2.12%
Data as of 4:09pm ET, 09/21/2021

Financials

Next reporting dateNovember 12, 2021
EPS forecast (this quarter)$0.64
Annual revenue (last year)$27.6B
Annual profit (last year)$3.2B
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts